GBH lays off 6 percent of staff due to funding cuts, rising costs, and stagnant revenues

Combined with layoffs last month at WORLD Channel, the cuts amount to 7 percent of GBH’s total workforce. 5:33 p.m.

BOLD TYPES

Pioneer law center adopts New England Legal Foundation brand as part of ‘strategic alliance’

Boston has essentially had two free-market-oriented, nonprofit law firms, the Pioneer Public Interest Law Center and the New England Legal Foundation. Now, there will be only one. 4:48 p.m.

US dependence on China for rare earth magnets is causing shortages

American automakers are the hardest hit, with executives warning that production at factories across the Midwest and South could be cut back in the coming days and weeks. 4:17 p.m.

Amid financial challenges, Point32Health hires a new chief executive

Patrick Gilligan, a former Blue Cross Blue Shield executive, will succeed Cain Hayes, who left the financially troubled insurer in September. 3:06 p.m.

BOLD TYPES

Hilina Ajakaiye is leaving Meet Boston for big role with national convention trade group

The No. 2 at Meet Boston will take a national job aiming to boost Black tourism in the US. 2:30 p.m.

Trump’s tariffs have launched global trade wars. Here’s a timeline of how we got here.

Long-threatened tariffs from President Trump have plunged the country into trade wars abroad — all while on-again, off-again new levies continue to escalate uncertainty. 2:18 p.m.

Tell us: How are you planning to afford GLP-1 drugs?

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your prescription? Planning to pay out of pocket if your coverage ends? We want to hear from you. 12:11 p.m.

mRNA, once lauded as a scientific marvel, is now a government target

Republican lawmakers and federal health officials alike are shunning messenger RNA, a basic building block of biology that proved its value during COVID, and that holds promise for combating the next pandemic and unlocking new cancer treatments. 10:45 a.m.

At-home health tests are here. But they aren’t always the best option.

Self-administered at-home tests are available for everything from thyroid function to HIV to cervical cancer. Here’s what doctors say you can test for at home, and when you should make the trek to your physician’s office. 10:40 a.m.

At-home health tests are here. But they aren’t always the best option.

Self-administered at-home tests are available for everything from thyroid function to HIV to cervical cancer. But when are they the right choice? 10:36 a.m.

Record labels in talks to license music to AI firms Udio, Suno

Universal Music Group, Warner Music Group and Sony Music Entertainment are pushing to collect license fees for their work and also receive a small amount of equity in Suno and Udio, two leaders among a crop of companies that use generative AI to help make music. 9:15 a.m.

Sanofi to buy immunology biotech Blueprint for $9.1 billion

Cambridge-based Blueprint Medicines brings a pipeline of experimental immunology treatments and one medicine already on sale for a rare condition known as systemic mastocytosis. 8:42 a.m.

INNOVATOR Q&A

Sleeping, eating, or sex? There’s a cannabis strain for that

A Rhode Island doctor’s new software aims to match customers with a strain based on scientific data. 5:55 a.m.

Trendlines

The Market Basket boardroom battle is a real-life ‘Succession’ saga

Arthur T. Demoulas’s ouster, like the hit HBO boardroom drama, is an example of the kind of ugly maneuvering that can happen when the relationships underpinning a family business go sour. 5:00 a.m.